• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Non-cardiac admissions most common for heart-failure patients in last year of life 

byJames EnglandandAnees Daud
July 3, 2019
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
CHADS-VASc score may help predict outcomes in heart failure
Share on FacebookShare on Twitter

1. In this retrospective analysis of patients with heart failure, admissions to the hospital for non-cardiac problems were more frequent than admissions for heart failure or cardiovascular (CV) disease.

2. The frequency of hospital admissions increased towards the time of death but without change in proportion of admissions for heart failure or CV disease.

Evidence Rating Level: 2 (Good)        

Study Rundown: Congestive heart failure (CHF) is a chronic medical condition with a high morbidity and mortality. Despite increases in multidisciplinary team approaches for heart failure management, care of patients towards the end of life is often not prioritized. Efforts to improve care for heart failure patients at the end of life will need to understand the common issues faced by this patient population. This study sought to evaluate the causes of medical decompensation in patients with heart failure in the last year of life. The retrospective analysis found that heart failure and cardiovascular disease were common reasons for hospital admission, but the majority of admissions were for non-cardiac issues. While hospitalization frequency increased towards the time of death, the proportion of admissions for cardiac and non-cardiac causes remained unchanged.

The findings of this study underscore the importance of recognizing non-cardiac issues in patients with end-stage CHF. The main strength of this study is the large cohort of heart failure patients in their final year of life. The limitations of the study include the lack of information on functional class, ejection fraction, and reliance on diagnostic codes for establishing cause of admission.

Click to read the study in JACC: Heart Failure

RELATED REPORTS

Placental abruption during pregnancy is not associated with increased risk of cardiovascular mortality in children

Physicians slightly more likely to die at home or hospice

High-flow nasal therapy with room air and fan therapy provide modest relief of dyspnea in advanced cancer patients who are not hypoxemic

Relevant Reading: Symptom Relief and Palliative Care during the Last Week of Life among Patients with Heart Failure: A National Register Study

In-Depth [retrospective cohort]: This study is a retrospective cohort analysis of patients in the Danish Central Population Register who received a CHF diagnosis from 2000 to 2015 and were started on heart failure therapy with angiotensin-converting enzyme inhibitors (ACEIs)/ angiotensin receptor blockers (ARBs) and beta blockers within 4 months after the diagnosis. Patients were excluded if they died after 2016 or had lived less than one year with a heart failure diagnosis. International Classification of Diseases and Related Health Problems 10 (ICD-10) diagnostic codes were used to establish heart failure diagnosis, presence of comorbidities, and reason for hospital admissions within 1 year of death.

The study found that of the 32,157 heart failure patients, 84% (n=26 561) were hospitalized at least one time in the year leading up to their death. Reasons for hospital admission included heart failure (12%, n=9 644), other CV causes (18%, 14 738) and non-CV related disease (64%, 51 696). Hospitalizations increased in frequency closer to the time of death but the proportion of admissions for non-CV causes did not change significantly.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular mortalitycongestive heart failurepalliative care
Previous Post

Tanezumab provides modest benefit for osteoarthritis

Next Post

Quick Take: Investigating causal relations between sleep traits and risk of breast cancer in women

RelatedReports

Cardiology

Placental abruption during pregnancy is not associated with increased risk of cardiovascular mortality in children

April 1, 2026
Increased risk of stillbirth recurrence after a previous stillbirth
Chronic Disease

Physicians slightly more likely to die at home or hospice

February 23, 2026
Chronic Disease

High-flow nasal therapy with room air and fan therapy provide modest relief of dyspnea in advanced cancer patients who are not hypoxemic

January 12, 2026
Dietary variety linked to greater increase in childhood BMI
Cardiology

Reducing saturated fat decreases mortality in high-risk individuals

December 15, 2025
Next Post
Age and breast cancer risk factors associated with false-positive mammography results

Quick Take: Investigating causal relations between sleep traits and risk of breast cancer in women

Aspirin therapy linked to fewer cases of preeclampsia

Quick Take: Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial

Reduced gestational weight gain with lifestyle intervention

Quick Take: Physical activity trajectories and mortality

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind October 12, 2026
  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.